Fundamental Hype listened to the $ACB earnings call and went through the quarterlies to bring you a look at the one and only Aurora Cannabis.
@BettingBruiser’s report on $ACB’s portfolio is a great read if you can get through it. We broke out a summary for a pre-earnings call amuse-bouche.
This pre-earnings look at $ACB’s ops is meant to give readers a look at their very unique production and inventory profile while building some background for a post-earnings look at the Alberta Cannabis giant.
Lots of inventory, but no supply? Does $WEED/$CGC’s have a scaling problem?
We’ve got low stocks, high inventories, conflicting reports and blame flying around like broccoli in a food fight.
$OGI had a banger of a quarter and is still one of our favorite Canadian cultivators in the latest marijuana datajam.
$EMC & $ALEF stand to come out ahead on $TLRY’s Natura deal. But can they keep their supply?
Breaking down the fundamentals behind the hype in the $GGB offer for $APHA.
$TLRY’s deal for Natura Naturals is putting on a clinic in risk pricing, just in time for our series on de-risking in the cannabis space.
$ACB’s made a $175M all-stock bid for private Whistler Medical after unloading some $TGOD. $CRON may have something to say about this before it’s over.